BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18719222)

  • 1. Endogenous regeneration in Parkinson's disease: do we need orthotopic dopaminergic neurogenesis?
    Hermann A; Storch A
    Stem Cells; 2008 Nov; 26(11):2749-52. PubMed ID: 18719222
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine and adult neurogenesis.
    Borta A; Höglinger GU
    J Neurochem; 2007 Feb; 100(3):587-95. PubMed ID: 17101030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The proliferative capacity of the subventricular zone is maintained in the parkinsonian brain.
    van den Berge SA; van Strien ME; Korecka JA; Dijkstra AA; Sluijs JA; Kooijman L; Eggers R; De Filippis L; Vescovi AL; Verhaagen J; van de Berg WD; Hol EM
    Brain; 2011 Nov; 134(Pt 11):3249-63. PubMed ID: 22075520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson's disease.
    Murrell W; Wetzig A; Donnellan M; Féron F; Burne T; Meedeniya A; Kesby J; Bianco J; Perry C; Silburn P; Mackay-Sim A
    Stem Cells; 2008 Aug; 26(8):2183-92. PubMed ID: 18535154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation and dopaminergic neuronal loss in Parkinson's disease: a complex matter.
    Hartmann A; Hunot S; Hirsch EC
    Exp Neurol; 2003 Dec; 184(2):561-4. PubMed ID: 14769349
    [No Abstract]   [Full Text] [Related]  

  • 6. Nondopaminergic neurons in Parkinson's disease.
    Hirsch EC; Orieux G; Muriel MP; Francois C; Feger J
    Adv Neurol; 2003; 91():29-37. PubMed ID: 12449099
    [No Abstract]   [Full Text] [Related]  

  • 7. Midbrain dopaminergic neurogenesis and behavioural recovery in a salamander lesion-induced regeneration model.
    Parish CL; Beljajeva A; Arenas E; Simon A
    Development; 2007 Aug; 134(15):2881-7. PubMed ID: 17611231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A perspective on transplantation therapy and stem cells for Parkinson's disease.
    Freed WJ
    Cell Transplant; 2004; 13(3):319-27. PubMed ID: 15191169
    [No Abstract]   [Full Text] [Related]  

  • 9. Biochemistry of Parkinson's disease: is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease?
    Kish SJ
    Adv Neurol; 2003; 91():39-49. PubMed ID: 12442662
    [No Abstract]   [Full Text] [Related]  

  • 10. The functional anatomy of noradrenergic neurons in Parkinson's disease.
    Soldani P; Fornai F
    Funct Neurol; 1999; 14(2):97-109. PubMed ID: 10399622
    [No Abstract]   [Full Text] [Related]  

  • 11. Transplanted dopaminergic neurons develop PD pathologic changes: a second case report.
    Kordower JH; Chu Y; Hauser RA; Olanow CW; Freeman TB
    Mov Disord; 2008 Dec; 23(16):2303-6. PubMed ID: 19006193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro analysis of Pitx3 in mesodiencephalic dopaminergic neuron maturation.
    Papanikolaou T; Amano T; Lennington J; Sink K; Farrar AM; Salamone J; Yang X; Conover JC
    Eur J Neurosci; 2009 Jun; 29(12):2264-75. PubMed ID: 19508691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced survival and function of neural stem cells-derived dopaminergic neurons under influence of olfactory ensheathing cells in parkinsonian rats.
    Shukla S; Chaturvedi RK; Seth K; Roy NS; Agrawal AK
    J Neurochem; 2009 Apr; 109(2):436-51. PubMed ID: 19222707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined treatment of neurotrophin-3 gene and neural stem cells is ameliorative to behavior recovery of Parkinson's disease rat model.
    Gu S; Huang H; Bi J; Yao Y; Wen T
    Brain Res; 2009 Feb; 1257():1-9. PubMed ID: 19111525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of transplantable dopamine neuron precursors at different stages of midbrain neurogenesis.
    Jönsson ME; Ono Y; Björklund A; Thompson LH
    Exp Neurol; 2009 Sep; 219(1):341-54. PubMed ID: 19555687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival and early functional integration of dopaminergic progenitor cells following transplantation in a rat model of Parkinson's disease.
    Hahn M; Timmer M; Nikkhah G
    J Neurosci Res; 2009 Jul; 87(9):2006-19. PubMed ID: 19235889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging restorative treatments for Parkinson's disease.
    Deierborg T; Soulet D; Roybon L; Hall V; Brundin P
    Prog Neurobiol; 2008 Aug; 85(4):407-32. PubMed ID: 18586376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of Lmx1a in the differentiation of human embryonic stem cells into midbrain dopamine neurons in culture and after transplantation into a Parkinson's disease model.
    Cai J; Donaldson A; Yang M; German MS; Enikolopov G; Iacovitti L
    Stem Cells; 2009 Jan; 27(1):220-9. PubMed ID: 18832589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related decline in neurogenesis: old cells or old environment?
    Zitnik G; Martin GM
    J Neurosci Res; 2002 Nov; 70(3):258-63. PubMed ID: 12391584
    [No Abstract]   [Full Text] [Related]  

  • 20. Absence of striatal newborn neurons with mature phenotype following defined striatal and cortical excitotoxic brain injuries.
    Deierborg T; Staflin K; Pesic J; Roybon L; Brundin P; Lundberg C
    Exp Neurol; 2009 Sep; 219(1):363-7. PubMed ID: 19427853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.